XML 67 R56.htm IDEA: XBRL DOCUMENT v3.21.1
Geneos Therapeutics, Inc. - Deconsolidation Accounting (Details) - USD ($)
Jun. 01, 2020
Mar. 31, 2021
Dec. 31, 2020
Noncontrolling Interest [Line Items]      
Fixed assets, net of accumulated depreciation   $ (10,930,312) $ (11,348,144)
Geneos Therapeutics, Inc.      
Noncontrolling Interest [Line Items]      
Working capital (excluding cash) $ (59,992)    
Note payable 171,620    
Fixed assets, net of accumulated depreciation (16,340)    
Carrying value of noncontrolling interest 3,181,640    
Fair value of investment in Geneos retained 3,618,998    
Gain on deconsolidation of Geneos (4,121,075)    
Decrease in cash resulting from the deconsolidation of Geneos $ 2,774,851